Frontiers in gene therapy for erectile dysfunction

International Journal of Impotence Research

Volumn 15, Issue , 2003, Pages S33-S40

  Christ, G J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Erectile dysfunction; Gene therapy; Penile erection

Indexed keywords

ADENOVIRUS VECTOR; ANTISENSE OLIGODEOXYNUCLEOTIDE; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCITONIN GENE RELATED PEPTIDE; CYCLIC GMP; GROWTH FACTOR; GUANYLATE CYCLASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE; PHOSPHODIESTERASE V; PLASMID VECTOR; POTASSIUM CHANNEL; RHO KINASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

CELL BASED GENE THERAPY; CONFERENCE PAPER; DNA VECTOR; ERECTILE DYSFUNCTION; GENE TECHNOLOGY; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN GENOME; MALE; MUSCLE DISEASE; PENIS ERECTION; PRIORITY JOURNAL; REGULATORY MECHANISM; SMOOTH MUSCLE;

GENE THERAPY; HUMANS; IMPOTENCE; MALE; PENILE ERECTION;

EID: 0142246427     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901070     Document Type: Article

References (37)

1. Butte A. The use and analysis of microarray data. Nat rev Drug Disc 2002; 1: 951-960.
2. Hanash SM et al. Integrating cancer genomics and proteomics in the post-genome era. Proteomics 2002; 2: 69-75.
3. Guttmacher AE, Collins FS. Genomic medicine—a primer. N Engl J Med 2002; 347: 1512-1520.
4. Somia N, Verma IM. Gene therapy: trials and tribulations. Nat Rev Genet 2000; 1: 91-99.
5. Scollay R. A brief overview of the past, present, and future. Gene Therapy. Ann NY Acad Sci 2001; 953: 26-30.
6. Carmen IH. A death in the laboratory: the politics of the Gelsinger aftermath. Mol Ther 2001; 3: 425-428.
7. Ferber D. Gene therapy: safer and virus-free. Science 2001; 23: 1638-1642.
8. Zallen DT. US Gene therapy in crisis. Trends Gene Ther 2000; 16: 272-275.
9. Garban H et al. Cloning of rat and human inducible penile nitric oxide synthase. Application for gene therapy of erectile dysfunction. Biol Reprod 1997; 56: 954-963.
10. Christ GJ et al. Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function. Am JPhysiol 1998; 275: H600-H608.
11. Champion HC et al. Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc Natl Acad Sci USA. 1999; 96: 11648-11652.
12. Bivalacqua TJ et al. Adenoviral gene transfer of endothelial nitric oxide synthase (eNOS) to the penis improves age-related erectile dysfunction in the rat. Int J Impot Res 2000; 12: S8-S17.
13. Magee TR et al. Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase. Biol Reprod 2002; 67: 20-28.
14. Tirney S et al. Nitric oxide synthase gene therapy for erectile dysfunction: comparison of plasmid adenovirus, and adenovirus-transduced myoblast vectors. Mol Urol 2001; 5: 37-43.
15. Bivalacqua TJ et al. Gene transfer of prepro-calcitonin gene-related peptide restores erectile function in the aged rat. Biol Reprod 2001; 65: 1371-1377.
16. Bakirciogla ME et al. The effect of adeno-associated virus mediated brain derived neurotrophic factor in an animal model of neurogenic impotence. J Urol 2001; 165: 2103-2109.
17. Bai WJ et al. The effects of antisense oligonucleotides on the cyclic nucleotide monophosphates in smooth muscle cells of human corpus cavernosum. Zhounghua Nan Ke Xue 2002; 8: 88-91.
18. Chitaley K et al. Adeno-associated viral gene transfer of dominant negative RhoA enhances erectile function in rats. Biochem Biophys Res Comm 2002; 298: 427-432.
19. Rehman J et al. Enhancement of physiologic erectile function with nitric oxide synthase gene therapy. J Urol 1997; 157 (Suppl.): 201.
20. + channels and gap junctions in urogenital smooth muscle: implications for improved understanding of urogenital function, disease and therapy. Curr Drug Targets 2001; 2: 1-20.
21. Christ GJ. K channels as molecular targets for the treatment of erectile dysfunction. J Androl 2002; 23: S10-S19.
22. Spektor M et al. K channels and human corporal smooth muscle cell tone: further evidence for the physiological relevance of the Maxi-K channel subtype to the regulation of human corporal smooth muscle tone in vitro. J Urol 2002; 167: 2628-2635.
23. Melman A, Christ GJ. Integrative erectile biology: the effects of age and disease on gap junctions and ion channels and their potential value to the treatment of erectile dysfunction. Urol Clin North Am 2001; 28: 217-231.
24. Ramanan SV, Brink PR, Christ GJ. Neuronal innervation, intracellular signal transduction and intercellular coupling: a model for syncytial tissue responses in the steady state. J Theor Biol 1998; 193: 69-84.
25. Rehman J et al. Diminished neurogenic-, but not pharmacologic-induced intracavernous pressure responses in the 3 month Streptozotocin (STZ)-diabetic rat. Am J Physiol 1997; 272: H1960-H1971.
26. Koransky ML, Robbins RC, Blau HM. VEGF gene delivery for treatment of ischemic cardiovascular disease. Trends Cardio-vascMed 2002; 12: 108-114.
27. Lue TF. Future treatment for ED: growth factors and gene therapy. Int J Impot Res 1999; 11: S56-S57.
28. Burchardt M et al. Expression of messenger ribonucleic acid splice variants for vascular endothelial growth factor in the penis of adult rats and humans. Biol Reprod 1999; 60: 398-404.
29. Lee Ming-Chan et al. The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction. J Urol 2002; 167: 761-767.
30. Wessells H, Williams SK. Endothelial cell transplantation into the corpus cavernosum: moving towards cell-based gene therapy. J Urol 1999; 162: 2162-2164.
31. Chancellor MB et al. Gene therapy strategies for urological dysfunction. Trends Mol Med 2001; 7: 301-306.
32. Bivalacqua TJ, HeBstrom WJG. Potential application of gene therapy for the treatment of erectile dysfunction. J Androl 2001; 22: 183-190.
33. Donatucci CF. Male sexual dysfunction-the new millennium. Curr Opin Urol 2000; 10: 313-317.
34. Schenk G, Melman A, Christ GJ. Gene therapy: future therapy for erectile dysfunction. Curr Urol Rep 2001; 2: 480-487.
35. Bivalacqua TJ et al. Potentiation of erectile response with the combination of endothelial NOS gene therapy and sildenafil in streptozotocin diabetic rats. Int J Impot Res 2002; 14 (Suppl 3): S12.
36. Christ GJ. Gene therapy for erectile dysfunction: where is it going? Curr Opin Urol 2002; 12: 497-501.
37. Bivalacqua TJ et al. Gene transfer of extracellular SOD to the penis reduces O2 and improves erectile function in aged rats. Am JPhysiol 2003; 284: H1408-H1421.